🇺🇸 FDA

Company profile · Sponsor

SAB

SAB Biotherapeutics

SABS · NYSE biotech MIAMI BEACH, FL, USA
Pipeline
8
Drugs
0
Patents
1

Quick answer

SAB (SABS) is a biotech company. headquartered in MIAMI BEACH, FL, USA. listed on NYSE. NovaPharmaNews links 8 pipeline programs, 0 drugs, and 1 patent to this profile..

Company facts

Ticker SABS
Exchange NYSE
Company type biotech
Headquarters MIAMI BEACH, FL, USA
SEC CIK 0001833214

Pipeline (8)

Search pipeline →

  1. bamlanivimab 7000mg

    SAB

    Coronavirus

    phase 3 mab completed

    1 trial

  2. High Dose SAB-142

    SAB

    Type 1 Diabetes

    phase 2 small molecule active

    1 trial

  3. SAB-142, SODIUM CHLORIDE

    SAB

    Type 1 Diabetes

    phase 2 small molecule active

    1 trial

  4. SAB-176

    SAB

    Influenza A H1N1

    phase 2 mab completed

    1 trial

  5. SAB-176

    SAB

    Influenza Type A

    phase 1 mab completed

    1 trial

  6. SAB-185

    SAB

    COVID-19

    phase 1 mab active

    2 trials

  7. SAB-301

    SAB

    Middle East Respiratory Syndrome Coronavirus

    phase 1 mab completed

    1 trial

  8. Single Ascending Dose of SAB-176

    SAB

    PHA1A

    phase 1 small molecule active

    1 trial

Patents (1)

Search patents →

  1. US 11975066

    Ungulate-derived polyclonal immunoglobulin specific for coronavirus protein and uses thereof

    Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is SAB?

SAB (SABS) is a biotech company. headquartered in MIAMI BEACH, FL, USA. listed on NYSE. NovaPharmaNews links 8 pipeline programs, 0 drugs, and 1 patent to this profile..

What pipeline programs does SAB sponsor?

We track 8 ClinicalTrials.gov-linked programs for SAB, including bamlanivimab 7000mg and 7 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does SAB company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.